We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BioTrove and Sitris Expand HTS Relationship
News

BioTrove and Sitris Expand HTS Relationship

BioTrove and Sitris Expand HTS Relationship
News

BioTrove and Sitris Expand HTS Relationship

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "BioTrove and Sitris Expand HTS Relationship "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

BioTrove has announced the expansion of its relationship with Sirtris Pharmaceuticals. As part of the ongoing relationship, BioTrove will use its proprietary RapidFire™ Lead Discovery service for assay development and high throughput screening on an undisclosed number of Sirtris targets.

RapidFire™ Lead Discovery uses high throughput mass spectrometry to perform label-free assays using native biological substrates enabling the screening of intractable targets.

“The expansion of our relationship with Sirtris provides further validation of the value of RapidFire™ Lead Discovery,” said Alan Carter, vice president of business development and field operations.

“Our expanding customer base continues to find new leads and information on valuable targets when compared to classical HTS methods.”

Advertisement